Tag Archives: high-throughput

Systems Biology Approaches and Drug Design

The reductionist way of “one gene-one disease-one drug” has made it difficult for the discovery of more effective drugs.  In addition to conventional phenotypic and drug target screens, new methodologies may improve the drug design process, including ligand- and structure-based … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , , | Leave a comment

Genetic Networks and Biomarkers

The post-genomic research based on large cohorts of preclinical studies have produced multi-dimensional genetic and transcriptomic data sets. The revelation of the molecular pathways and cellular networks associated with various diseases may promote the systems biology studies of the onset … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , | Leave a comment

Systems Biology and Companion Diagnostics

The development in high-throughput (HTP) technologies and computational biology may help define the next generation of biomarkers. By providing an integrative viewpoint, systems biology may improve the understanding of the complexity in biological systems. The assemblage of interacting molecular elements … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , , | Leave a comment

Biomarkers, Oncology, and Precision Medicine

The identification of biomarkers is becoming more and more important in biomedicine, especially for the clinical practice. This is because biomarkers often contain valuable information about the pathology of the diseases such as cancers. Such information is useful for better … Continue reading

Posted in Biomarkers, Systems Biology | Tagged , , , , , , , , , | Leave a comment

Systems Biology Technologies and Cancer Immunotherapy

Decades of scientific studies have demonstrated the essential role of the immune system in cancer pathology and clinical treatment. The immune system may regulate the growth of tumors via the complex interactions among molecules, genes, cells, and organs. The elucidation … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , , , , , | Leave a comment

Network Interactions, Interactomes, and Drug Discovery

Because genes and proteins are functioning in complex networks and interactions, one molecule may influence other cellular elements in a broad range. These interactions can be studied in “interactomes”, a term referring to the protein-protein interaction networks (Chautard et al., … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , , , , | Leave a comment

Systems Biology and Neurodegenerative Diseases

Neurodegenerative diseases (NDs) are complex disorders that affect more than 40 million people globally (Wood et al., 2015). The multifaceted variations in the pathophysiology of the diseases make it difficult for effective therapy or prevention of the disease progression. More … Continue reading

Posted in Psychiatric Genetics, Systems Biology | Tagged , , , , , , , , , , | Leave a comment

Systems Biology and Drug Screening

Conventional drug design mostly uses the ligand and structure-based approaches (Prathipati and Mizuguchi, 2015). With the advancement in functional genomics and the availability of high-throughput (HTP) data, information on interactive molecular networks can be used to analyze the efficacy and … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , , | Leave a comment

Nutritional Systems Biology and Type 2 Diabetes

Systems biology studies include the investigations in various “omics” areas, such as genomics, transcriptomics, proteomics, metabolomics, epigenomics, as well as microbiomics. Combining both computational and experimental biology, systems biology aims at prediction of the dynamical processes and the description of … Continue reading

Posted in Systems Biology | Tagged , , , , , , , , , , , , | Leave a comment

Systems biology and “omics” technologies for better drug discovery and outcome studies in cancer treatment

The multiple platforms using the “omics” technologies and the integration of systems biology approaches including both experimental and computational methods would support both drug target discovery and clinical outcome studies, especially in cancer treatment. For instance, immunotherapies have become an … Continue reading

Posted in Immune, Systems Biology, Systems Medicine | Tagged , , , , , , , , , , , , , , , | Leave a comment